Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barry Reiner, MD
Barry J. Reiner, MD, LLC, Baltimore, Maryland
Principal Investigator - David Domek, MD
Lynn health Science Institute, Oklahoma City
Principal Investigator - Dennis Brenner, MD
St. Barnabas Medical Center, Livingston, New Jersey
Principal Investigator - Diane Merritt, MD
Washington University, St. Louis, Missouri
Principal Investigator - Douglas Rogers, MD
Cleveland Clinic, Ohio
Principal Investigator - Erica Eugster, MD
James Whitcomb Riley Hospital for Children, Indianapolis, Indiana
Principal Investigator - Fernando Cassorla, MD
IDIMI, Santiago, Chile
Principal Investigator - Gad Kletter, MD
Swedish Pediatric Specialist, Seattle, Washington
Principal Investigator - Galal Salem, MD
SRCR, Inc, Bell Gardens, California
Principal Investigator - Heidi Shea, MD
Endocrine Associates of Dallas, Plano, Texas
Principal Investigator - Javier Aisenberg, MD
Hackensack university medical center, New Jersey
Principal Investigator - Joshua Yang, MD
Arnold Palmer Pediatric Endocrinology Practice, Orlando, Florida
Principal Investigator - Karen Klein, MD
Children's National Medical Center, San Diego, California
Principal Investigator - Kathleen Bethin, MD
Women's & Children's Hospital of Buffalo, New York
Principal Investigator - Lawrence Silverman, MD
Goryeb Children's Hospital, Morristown, New Jersey
Principal Investigator - Mark Rappaport, MD
Pediatric Endocrine Associates, Atlanta, Georgia
Principal Investigator - Nancy Wright, MD
Nancy Wright MD P.A., Tallahasse, Florida
Principal Investigator - Opada Alzohaili, MD
Alzohaili Medical Consultants, Dearborn, Michigan
Principal Investigator - Oscar Flores, MD
Hospital Universitario de Monterrey, Mexico
Principal Investigator - Paul Kaplowitz, MD
Children's National Medical Center, Washington
Principal Investigator - Peter Lee, MD
Penn State Hershey Children's Hospital, Pennsylvania
Principal Investigator - Quentin Van Meter, MD
Van Meter Pediatric Endocrinology, Peachtree City, Georgia
Principal Investigator - Ricardo Gomez, MD
Children's Hospital, New Orleans, Louisiana
Principal Investigator - Susan Rose, MD
Cincinnati Children's Hospital, Ohio
Principal Investigator - Tala Dajani, MD
Pediatric Endocrinology of Phoenix, Arizona
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Idimi
Santiago, Chile
- Hospital Universitario de Monterrey
Monterrey, Mexico
- Pediatric Endocrinology of Phoenix
Phoenix, Arizona, United States
- Children'S National Medical Center
San Diego, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Arnold Palmer Pediatric Endocrinology Practice
Orlando, Florida, United States
- Nancy Wright Md P.A.
Tallahassee, Florida, United States
- Washington University
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Women'S & Children'S Hospital of Buffalo
Buffalo, New York, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Lynn Health Science Institute
Oklahoma City, Oklahoma, United States
- Swedish Pediatric Specialist
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2012
- Primary completion
- 31 Aug 2013
- Completion
- 31 Jul 2014
- Last update posted
- 28 Jul 2017
- Registered enrollment
- 44
- Registry id
- NCT01467882
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.